Improved influenza vaccine efficacy through infection mimicry
Ended Project Grant Awarded Last action
- Award ID
- R44AI142948
- Recipient
-
Vaxess Technologies, Inc. UEI HNLJN8YZPVJ3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,296,898
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $3,296,998.00 Federal
- $999,900.00 Non-federal
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $999,900 | $0 | |
| Amendment | $999,900 | $999,900 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $997,500 | $0 | |
| Original award | $299,698 | $0 |
Quick answers
Who received award R44AI142948?
R44AI142948 was awarded to Vaxess Technologies, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2019.
How much is award R44AI142948 worth?
$4,296,898 has been obligated on R44AI142948: $3,296,998 in federal funding and $999,900 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award